Position in ABBV
as of Jun 30, 2026
· filed Aug 18, 2026
Position Value
$49,261,298
+$5,613,013 QoQ
Shares Held
195,761
-2.5% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#369
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2025CallValue
$0
CallShares
0
PutValue
$625,158
PutShares
2,700
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Beacon Pointe Advisors, LLC holds $381,609,244 across 14 Drug Manufacturers - General names. ABBV ranks #3 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
365,648 | $92,863,622 | |
| 2 | LLY |
ELI LILLY & Co
|
61,241 | $73,454,298 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
195,761 | $49,261,298 | |
| 4 | MRK |
Merck & Co., Inc.
|
363,066 | $46,653,981 | |
| 5 | AMGN |
Amgen Inc
|
108,053 | $39,128,152 | |
| 6 | PFE |
Pfizer Inc
|
1,161,607 | $27,971,496 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
232,697 | $13,408,001 | |
| 8 | NVS |
Novartis AG
|
84,234 | $13,201,152 |
All Filings in ABBV
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,261,298 | 195,761 | Shares | Sole | 2026-08-18 | |
| 2026-03-31 | $43,648,285 | 200,691 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,945,717 | 152,942 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $29,796,882 | 128,690 | Shares | Sole | 2025-11-14 | |
| 2025-09-30 | $625,158 | 2,700 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $23,639,635 | 127,355 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $25,809,930 | 123,186 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $21,961,232 | 123,586 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $25,819,127 | 130,743 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $23,257,768 | 135,598 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $25,268,924 | 138,764 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $24,985,503 | 161,228 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $25,510,724 | 171,144 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $13,897,534 | 103,151 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $23,092,075 | 144,896 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,658,749 | 78,329 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,494,148 | 78,192 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $11,890,729 | 77,636 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $17,584,720 | 108,474 | Shares | Sole | 2022-05-17 | |
| 2021-12-31 | $7,369,551 | 54,428 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,898,825 | 63,955 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,693,483 | 41,668 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $2,176,845 | 20,115 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $2,055,029 | 19,179 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $1,394,870 | 15,925 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,670,729 | 17,017 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $1,356,638 | 17,806 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||